Acadia Healthcare (NASDAQ:ACHC) Releases FY 2025 Earnings Guidance

Key Points

• Acadia Healthcare has provided FY 2025 earnings guidance of $2.450-$2.650 per share, lower than the consensus estimate of $2.669, along with revenue guidance of $3.3 billion-$3.4 billion.
• Shares of Acadia Healthcare traded at $21.76, with a market capitalization of $2 billion and a price-to-earnings ratio of 10.72.
• Recent analyst reports have led to a mix of ratings changes, with a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 2.450-2.65 for the period, compared to the consensus estimate of 2.669. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.3 billion.

Analyst Ratings Changes

Several analysts recently issued reports on the company. UBS Group lowered their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday. KeyCorp lowered their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Barclays lowered their price target on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a report on Thursday. Mizuho lowered their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th. Finally, Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $44.75.

Acadia Healthcare Stock Performance

NASDAQ ACHC traded up $1.04 during trading hours on Friday, reaching $19.24. The company's stock had a trading volume of 2,850,657 shares, compared to its average volume of 1,991,195. The company has a current ratio of 1.32, a quick ratio of 1.35 and a debt-to-equity ratio of 0.73. The business has a 50-day simple moving average of $22.18 and a 200 day simple moving average of $27.88. Acadia Healthcare has a 52 week low of $17.13 and a 52 week high of $82.40. The stock has a market cap of $1.78 billion, a PE ratio of 12.74, a PEG ratio of 3.53 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. During the same quarter last year, the company posted $0.91 earnings per share. Acadia Healthcare's revenue was up 9.2% on a year-over-year basis. Equities research analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Acadia Healthcare during the first quarter valued at approximately $1,600,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Acadia Healthcare by 8.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company's stock valued at $10,337,000 after buying an additional 27,207 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company's stock valued at $21,170,000 after buying an additional 121,444 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.